Literature DB >> 28017549

Gender effect on non-motor symptoms in Parkinson's disease: are men more at risk?

A Nicoletti1, R Vasta1, G Mostile1, G Nicoletti2, G Arabia3, G Iliceto4, P Lamberti4, R Marconi5, L Morgante6, P Barone7, A Quattrone8, M Zappia9.   

Abstract

INTRODUCTION: Several gender differences have been reported in Parkinson's Disease (PD). We evaluated the burden of non-motor symptoms (NMS) in PD and the possible gender differences in their occurrence.
METHODS: The FRAGAMP study is a large multicenter case-control study. PD patients and controls underwent a face-to-face interview and a neurological examination performed by trained neurologists. Presence of NMS was investigated using a standardized questionnaire; cognitive impairment and depression were assessed using the Mini Mental State Examination and the Hamilton Depression Rating Scale respectively.
RESULTS: 585 PD patients (59.5% men) and 481 controls (34.9% men) were enrolled in the study. All NMS were significantly more frequent among PD patients than controls. PD women showed a significantly higher frequency of depression and urinary disturbances than parkinsonian men; a close frequency among PD women and men was recorded for hallucination, cognitive impairment and sleep disorders. Nonetheless, with respect to the control population, according to logistic regression stratified by sex and adjusted by age, PD men showed a stronger positive significant association with almost all NMS compared to women, excepting for urinary disturbances. The strongest association among PD men was recorded for cognitive impairment (adjusted OR 5.44 for men and 2.82 for women) and depression (adjusted OR 30.88 for men and 12.72 for women).
CONCLUSIONS: With respect to the general population, presence of NMS was stronger associated with male gender. Our data suggest that the presence of NMS among PD men is more strictly due to the neurodegenerative processes related to PD.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Case-control studies; Gender effect; Non-motor symptoms; Parkinson's disease/Parkinsonism

Mesh:

Year:  2016        PMID: 28017549     DOI: 10.1016/j.parkreldis.2016.12.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  12 in total

Review 1.  LRRK2 and Proteostasis in Parkinson's Disease.

Authors:  María Dolores Pérez-Carrión; Inmaculada Posadas; Javier Solera; Valentín Ceña
Journal:  Int J Mol Sci       Date:  2022-06-18       Impact factor: 6.208

2.  Biological Sex and Sex Hormone Impacts on Deficits in Episodic-Like Memory in a Rat Model of Early, Pre-motor Stages of Parkinson's Disease.

Authors:  Meagan R Conner; Doyeon Jang; Brenda J Anderson; Mary F Kritzer
Journal:  Front Neurol       Date:  2020-09-17       Impact factor: 4.003

3.  Drug Choices and Advancements for Managing Depression in Parkinson's Disease.

Authors:  Francesca Assogna; Clelia Pellicano; Cinzia Savini; Lucia Macchiusi; Gaia R Pellicano; Marika Alborghetti; Carlo Caltagirone; Gianfranco Spalletta; Francesco E Pontieri
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

4.  Sex-related differences in homebound advanced Parkinson's disease patients.

Authors:  Lynda Nwabuobi; William Barbosa; Meghan Sweeney; Sarah Oyler; Talia Meisel; Alessandro Di Rocco; Joshua Chodosh; Jori E Fleisher
Journal:  Clin Interv Aging       Date:  2019-07-31       Impact factor: 4.458

5.  Sex effects on clinical features in LRRK2 G2385R carriers and non-carriers in Parkinson's disease.

Authors:  Shi-Shuang Cui; Rao Fu; Juan-Juan Du; Yi-Qi Lin; Pei Huang; Chao Gao; Hai-Yan Zhou; Sheng-Di Chen
Journal:  BMC Neurosci       Date:  2021-03-26       Impact factor: 3.288

6.  Sex and onset-age-related features of excessive daytime sleepiness and night-time sleep in patients with Parkinson's disease.

Authors:  Ming Liu; Ya-Jun Luo; Han-Ying Gu; Yi-Ming Wang; Man-Hua Liu; Kai Li; Jiao Li; Sheng Zhuang; Yun Shen; Hong Jin; Jing Chen; Cheng-Jie Mao; Chun-Feng Liu
Journal:  BMC Neurol       Date:  2021-04-19       Impact factor: 2.474

7.  Executive functioning and serum lipid fractions in Parkinson's disease-a possible sex-effect: the PACOS study.

Authors:  Antonina Luca; Roberto Monastero; Calogero Edoardo Cicero; Roberta Baschi; Giulia Donzuso; Giovanni Mostile; Vincenzo Restivo; Lucia Di Giorgi; Maria Caccamo; Mario Zappia; Alessandra Nicoletti
Journal:  J Neural Transm (Vienna)       Date:  2022-01-13       Impact factor: 3.850

8.  Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson's disease.

Authors:  Megan C Bakeberg; Anastazja M Gorecki; Jade E Kenna; Alexa Jefferson; Michelle Byrnes; Soumya Ghosh; Malcolm K Horne; Sarah McGregor; Rick Stell; Sue Walters; Paola Chivers; Samantha J Winter; Frank L Mastaglia; Ryan S Anderton
Journal:  J Neurol       Date:  2021-01-05       Impact factor: 4.849

9.  Gender differences in motor and non-motor symptoms in early Parkinson disease.

Authors:  Kyung Wook Kang; Seong-Min Choi; Byeong C Kim
Journal:  Medicine (Baltimore)       Date:  2022-01-21       Impact factor: 1.889

10.  Elevated HDL Levels Linked to Poorer Cognitive Ability in Females With Parkinson's Disease.

Authors:  Megan C Bakeberg; Anastazja M Gorecki; Jade E Kenna; Alexa Jefferson; Michelle Byrnes; Soumya Ghosh; Malcolm K Horne; Sarah McGregor; Rick Stell; Sue Walters; Frank L Mastaglia; Ryan S Anderton
Journal:  Front Aging Neurosci       Date:  2021-06-11       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.